Connection
Satish Garg to Insulin Detemir
This is a "connection" page, showing publications Satish Garg has written about Insulin Detemir.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.469 |
|
|
|
-
Ji L, Zhang P, Zhu D, Lu J, Guo X, Wu Y, Li X, Ji J, Jia W, Yang W, Zou D, Zhou Z, Gao Y, Garg SK, Pan C, Weng J, Paul SK. Comparative effectiveness and safety of different basal insulins in a real-world setting. Diabetes Obes Metab. 2017 08; 19(8):1116-1126.
Score: 0.138
-
Shah VN, Moser EG, Blau A, Dhingra M, Garg SK. The future of basal insulin. Diabetes Technol Ther. 2013 Sep; 15(9):727-32.
Score: 0.108
-
Garg SK. The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review. Diabetes Technol Ther. 2010 Jan; 12(1):11-24.
Score: 0.084
-
Garg SK, Naik RG. Long-acting insulin analogs versus human insulins. Diabetes Technol Ther. 2008 Oct; 10(5):331-2.
Score: 0.077
-
Garg SK. New insulin analogues. Diabetes Technol Ther. 2005 Oct; 7(5):813-7.
Score: 0.062